Wang XW - Search Results

1

Combined immune checkpoint inhibition with durvalumab and tremelimumab with and without radiofrequency ablation in patients with advanced biliary tract carcinoma.

Monge C, Xie C, Myojin Y, Coffman-D'Annibale KL, Hrones D, Brar G, Wang S, Budhu A, Figg WD, Cam M, Finney R, Levy EB, Kleiner DE, Steinberg SM, Wang XW, Redd B, Wood BJ, Greten TF. Monge C, et al. Among authors: wang xw, wang s. Cancer Med. 2024 Feb;13(3):e6912. doi: 10.1002/cam4.6912. Epub 2024 Jan 11. Cancer Med. 2024. PMID: 38205877 Free PMC article.

2

Cancer-associated molecular signature in the tissue samples of patients with cirrhosis.

Kim JW, Ye Q, Forgues M, Chen Y, Budhu A, Sime J, Hofseth LJ, Kaul R, Wang XW. Kim JW, et al. Among authors: wang xw. Hepatology. 2004 Feb;39(2):518-27. doi: 10.1002/hep.20053. Hepatology. 2004. PMID: 14768006

3

Temporal and spatial control of nucleophosmin by the Ran-Crm1 complex in centrosome duplication.

Wang W, Budhu A, Forgues M, Wang XW. Wang W, et al. Among authors: wang xw. Nat Cell Biol. 2005 Aug;7(8):823-30. doi: 10.1038/ncb1282. Epub 2005 Jul 24. Nat Cell Biol. 2005. PMID: 16041368

4

The molecular signature of metastases of human hepatocellular carcinoma.

Budhu AS, Zipser B, Forgues M, Ye QH, Sun Z, Wang XW. Budhu AS, et al. Among authors: wang xw. Oncology. 2005;69 Suppl 1:23-7. doi: 10.1159/000086628. Epub 2005 Sep 19. Oncology. 2005. PMID: 16210873 Review.

5

Loading and unloading: orchestrating centrosome duplication and spindle assembly by Ran/Crm1.

Budhu AS, Wang XW. Budhu AS, et al. Among authors: wang xw. Cell Cycle. 2005 Nov;4(11):1510-4. doi: 10.4161/cc.4.11.2187. Epub 2005 Nov 20. Cell Cycle. 2005. PMID: 16294017 Free PMC article. Review.

6

Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironment.

Budhu A, Forgues M, Ye QH, Jia HL, He P, Zanetti KA, Kammula US, Chen Y, Qin LX, Tang ZY, Wang XW. Budhu A, et al. Among authors: wang xw. Cancer Cell. 2006 Aug;10(2):99-111. doi: 10.1016/j.ccr.2006.06.016. Cancer Cell. 2006. PMID: 16904609 Free article.

7

The role of cytokines in hepatocellular carcinoma.

Budhu A, Wang XW. Budhu A, et al. Among authors: wang xw. J Leukoc Biol. 2006 Dec;80(6):1197-213. doi: 10.1189/jlb.0506297. Epub 2006 Aug 31. J Leukoc Biol. 2006. PMID: 16946019 Review.

8

Gene expression profiling reveals potential biomarkers of human hepatocellular carcinoma.

Jia HL, Ye QH, Qin LX, Budhu A, Forgues M, Chen Y, Liu YK, Sun HC, Wang L, Lu HZ, Shen F, Tang ZY, Wang XW. Jia HL, et al. Among authors: wang l, wang xw. Clin Cancer Res. 2007 Feb 15;13(4):1133-9. doi: 10.1158/1078-0432.CCR-06-1025. Clin Cancer Res. 2007. PMID: 17317821

9

Induction of a unique gene expression profile in primary human hepatocytes by hepatitis C virus core, NS3 and NS5A proteins.

Budhu A, Chen Y, Kim JW, Forgues M, Valerie K, Harris CC, Wang XW. Budhu A, et al. Among authors: wang xw. Carcinogenesis. 2007 Jul;28(7):1552-60. doi: 10.1093/carcin/bgm075. Epub 2007 Apr 2. Carcinogenesis. 2007. PMID: 17404395

10

Future of molecular profiling of human hepatocellular carcinoma.

Roessler S, Budhu A, Wang XW. Roessler S, et al. Among authors: wang xw. Future Oncol. 2007 Aug;3(4):429-39. doi: 10.2217/14796694.3.4.429. Future Oncol. 2007. PMID: 17661718 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,581 results

Search Page